{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:36:44Z","timestamp":1790141804440,"version":"4.0.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,2,14]],"date-time":"2014-02-14T00:00:00Z","timestamp":1392336000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/ncomms4303","type":"journal-article","created":{"date-parts":[[2014,2,14]],"date-time":"2014-02-14T09:59:25Z","timestamp":1392371965000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":124,"title":["IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling"],"prefix":"10.1038","volume":"5","author":[{"given":"Ding-Sheng","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Fei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Hai","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter P.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Bond Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinliang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzeng","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Chang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,14]]},"reference":[{"key":"BFncomms4303_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrcardio.2010.165","volume":"8","author":"AL Bui","year":"2011","unstructured":"Bui, A. L., Horwich, T. B. & Fonarow, G. C. Epidemiology and risk profile of heart failure. Nat. Rev. Cardiol. 8, 30\u201341 (2011).","journal-title":"Nat. Rev. Cardiol."},{"key":"BFncomms4303_CR2","first-page":"e6","volume":"127","author":"AS Go","year":"2013","unstructured":"Go, A. S. et al. Heart disease and stroke statistics\u20142013 update: a report from the American Heart Association. Circulation 127, e6\u2013e245 (2013).","journal-title":"Circulation"},{"key":"BFncomms4303_CR3","doi-asserted-by":"publisher","first-page":"13818","DOI":"10.1073\/pnas.1008397107","volume":"107","author":"H Li","year":"2010","unstructured":"Li, H. et al. Regulator of G protein signaling 5 protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload. Proc. Natl Acad. Sci. USA 107, 13818\u201313823 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms4303_CR4","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nrm1983","volume":"7","author":"J Heineke","year":"2006","unstructured":"Heineke, J. & Molkentin, J. D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat. Rev. Mol. Cell. Biol. 7, 589\u2013600 (2006).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"BFncomms4303_CR5","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1161\/HYPERTENSIONAHA.111.00614","volume":"61","author":"DS Jiang","year":"2013","unstructured":"Jiang, D. S. et al. Role of interferon regulatory factor 4 in the regulation of pathological cardiac hypertrophy. Hypertension 61, 1193\u20131202 (2013).","journal-title":"Hypertension"},{"key":"BFncomms4303_CR6","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1161\/HYPERTENSIONAHA.113.01506","volume":"63","author":"DS Jiang","year":"2013","unstructured":"Jiang, D. S. et al. Signal regulatory protein-alpha protects against cardiac hypertrophy via the disruption of toll-like receptor 4 signaling. Hypertension 63, 96\u2013104 (2013).","journal-title":"Hypertension"},{"key":"BFncomms4303_CR7","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1161\/CIRCRESAHA.111.260729","volume":"110","author":"Q Liu","year":"2012","unstructured":"Liu, Q., Chen, Y., Auger-Messier, M. & Molkentin, J. D. Interaction between NFkappaB and NFAT coordinates cardiac hypertrophy and pathological remodeling. Circ. Res. 110, 1077\u20131086 (2012).","journal-title":"Circ. Res."},{"key":"BFncomms4303_CR8","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1182\/blood-2010-06-290700","volume":"117","author":"L Li","year":"2011","unstructured":"Li, L., Jin, H., Xu, J., Shi, Y. & Wen, Z. Irf8 regulates macrophage versus neutrophil fate during zebrafish primitive myelopoiesis. Blood 117, 1359\u20131369 (2011).","journal-title":"Blood"},{"key":"BFncomms4303_CR9","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1146\/annurev.immunol.26.021607.090400","volume":"26","author":"T Tamura","year":"2008","unstructured":"Tamura, T., Yanai, H., Savitsky, D. & Taniguchi, T. The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 26, 535\u2013584 (2008).","journal-title":"Annu. Rev. Immunol."},{"key":"BFncomms4303_CR10","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nri3088","volume":"11","author":"T Lawrence","year":"2011","unstructured":"Lawrence, T. & Natoli, G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunol. 11, 750\u2013761 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"BFncomms4303_CR11","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/ni.2304","volume":"13","author":"H Xu","year":"2012","unstructured":"Xu, H. et al. Notch-RBP-J signaling regulates the transcription factor IRF8 to promote inflammatory macrophage polarization. Nat. Immunol. 13, 642\u2013650 (2012).","journal-title":"Nat. Immunol."},{"key":"BFncomms4303_CR12","doi-asserted-by":"publisher","first-page":"4028","DOI":"10.1182\/blood-2008-01-129049","volume":"112","author":"H Wang","year":"2008","unstructured":"Wang, H. et al. IRF8 regulates B-cell lineage specification, commitment, and differentiation. Blood 112, 4028\u20134038 (2008).","journal-title":"Blood"},{"key":"BFncomms4303_CR13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1056\/NEJMoa1100066","volume":"365","author":"S Hambleton","year":"2011","unstructured":"Hambleton, S. et al. IRF8 mutations and human dendritic-cell immunodeficiency. N. Engl. J. Med. 365, 127\u2013138 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFncomms4303_CR14","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1038\/nm.2007","volume":"15","author":"B Zhao","year":"2009","unstructured":"Zhao, B. et al. Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis. Nat. Med. 15, 1066\u20131071 (2009).","journal-title":"Nat. Med."},{"key":"BFncomms4303_CR15","doi-asserted-by":"publisher","first-page":"e1002097","DOI":"10.1371\/journal.pgen.1002097","volume":"7","author":"JF Marquis","year":"2011","unstructured":"Marquis, J. F. et al. Interferon regulatory factor 8 regulates pathways for antigen presentation in myeloid cells and during tuberculosis. PLoS. Genet. 7, e1002097 (2011).","journal-title":"PLoS. Genet."},{"key":"BFncomms4303_CR16","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/nri1900","volume":"6","author":"K Honda","year":"2006","unstructured":"Honda, K. & Taniguchi, T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 6, 644\u2013658 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"BFncomms4303_CR17","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1074\/jbc.M707704200","volume":"283","author":"M Alter-Koltunoff","year":"2008","unstructured":"Alter-Koltunoff, M. et al. Innate immunity to intraphagosomal pathogens is mediated by interferon regulatory factor 8 (IRF-8) that stimulates the expression of macrophage-specific Nramp1 through antagonizing repression by c-Myc. J. Biol. Chem. 283, 2724\u20132733 (2008).","journal-title":"J. Biol. Chem."},{"key":"BFncomms4303_CR18","doi-asserted-by":"publisher","first-page":"44025","DOI":"10.1074\/jbc.M307954200","volume":"278","author":"M Alter-Koltunoff","year":"2003","unstructured":"Alter-Koltunoff, M. et al. Nramp1-mediated innate resistance to intraphagosomal pathogens is regulated by IRF-8, PU.1, and Miz-1. J. Biol. Chem. 278, 44025\u201344032 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFncomms4303_CR19","doi-asserted-by":"publisher","first-page":"10073","DOI":"10.1074\/jbc.M507788200","volume":"281","author":"J Zhao","year":"2006","unstructured":"Zhao, J. et al. IRF-8\/interferon (IFN) consensus sequence-binding protein is involved in Toll-like receptor (TLR) signaling and contributes to the cross-talk between TLR and IFN-gamma signaling pathways. J. Biol. Chem. 281, 10073\u201310080 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFncomms4303_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s12026-009-8125-6","volume":"46","author":"SI Abrams","year":"2010","unstructured":"Abrams, S. I. A multi-functional role of interferon regulatory factor-8 in solid tumor and myeloid cell biology. Immunol. Res. 46, 59\u201371 (2010).","journal-title":"Immunol. Res."},{"key":"BFncomms4303_CR21","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1158\/0008-5472.CAN-10-2493","volume":"71","author":"X Hu","year":"2011","unstructured":"Hu, X. et al. IRF8 regulates acid ceramidase expression to mediate apoptosis and suppresses myelogeneous leukemia. Cancer Res. 71, 2882\u20132891 (2011).","journal-title":"Cancer Res."},{"key":"BFncomms4303_CR22","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1161\/HYPERTENSIONAHA.110.149963","volume":"56","author":"H Huang","year":"2010","unstructured":"Huang, H. et al. Tumor suppressor A20 protects against cardiac hypertrophy and fibrosis by blocking transforming growth factor-beta-activated kinase 1-dependent signaling. Hypertension 56, 232\u2013239 (2010).","journal-title":"Hypertension"},{"key":"BFncomms4303_CR23","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1161\/CIRCULATIONAHA.109.868554","volume":"120","author":"D Oceandy","year":"2009","unstructured":"Oceandy, D. et al. Tumor suppressor Ras-association domain family 1 isoform A is a novel regulator of cardiac hypertrophy. Circulation 120, 607\u2013616 (2009).","journal-title":"Circulation"},{"key":"BFncomms4303_CR24","doi-asserted-by":"publisher","first-page":"11381","DOI":"10.1073\/pnas.1019711108","volume":"108","author":"S Sharma","year":"2011","unstructured":"Sharma, S. et al. Dephosphorylation of the nuclear factor of activated T cells (NFAT) transcription factor is regulated by an RNA-protein scaffold complex. Proc. Natl Acad. Sci. USA 108, 11381\u201311386 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms4303_CR25","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1747-0285.2006.00360.x","volume":"67","author":"M Kuriyama","year":"2006","unstructured":"Kuriyama, M. et al. A cell-permeable NFAT inhibitor peptide prevents pressure-overload cardiac hypertrophy. Chem. Biol. Drug. Des. 67, 238\u2013243 (2006).","journal-title":"Chem. Biol. Drug. Des."},{"key":"BFncomms4303_CR26","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.yjmcc.2008.09.002","volume":"46","author":"JD Molkentin","year":"2009","unstructured":"Molkentin, J. D. & Robbins, J. With great power comes great responsibility: using mouse genetics to study cardiac hypertrophy and failure. J. Mol. Cell. Cardiol. 46, 130\u2013136 (2009).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"BFncomms4303_CR27","doi-asserted-by":"publisher","first-page":"16258","DOI":"10.1073\/pnas.1203870109","volume":"109","author":"M Vaeth","year":"2012","unstructured":"Vaeth, M. et al. Dependence on nuclear factor of activated T-cells (NFAT) levels discriminates conventional T cells from Foxp3+ regulatory T cells. Proc. Natl Acad. Sci. USA 109, 16258\u201316263 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms4303_CR28","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1161\/01.RES.0000109415.17511.18","volume":"94","author":"BJ Wilkins","year":"2004","unstructured":"Wilkins, B. J. et al. Calcineurin\/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ. Res. 94, 110\u2013118 (2004).","journal-title":"Circ. Res."},{"key":"BFncomms4303_CR29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0092-8674(00)81573-1","volume":"93","author":"JD Molkentin","year":"1998","unstructured":"Molkentin, J. D. et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93, 215\u2013228 (1998).","journal-title":"Cell"},{"key":"BFncomms4303_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1161\/CIRCRESAHA.109.201236","volume":"105","author":"GS Pitt","year":"2009","unstructured":"Pitt, G. S. Calcineurin finds a new partner in the L-type Ca2+ channel. Circ. Res. 105, 7\u20138 (2009).","journal-title":"Circ. Res."},{"key":"BFncomms4303_CR31","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.1073\/pnas.041614798","volume":"98","author":"BA Rothermel","year":"2001","unstructured":"Rothermel, B. A. et al. Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo. Proc. Natl Acad. Sci. USA 98, 3328\u20133333 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms4303_CR32","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1073\/pnas.051033698","volume":"98","author":"LA Leinwand","year":"2001","unstructured":"Leinwand, L. A. Calcineurin inhibition and cardiac hypertrophy: a matter of balance. Proc. Natl Acad. Sci. USA 98, 2947\u20132949 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms4303_CR33","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00262-009-0804-6","volume":"59","author":"D Savitsky","year":"2010","unstructured":"Savitsky, D., Tamura, T., Yanai, H. & Taniguchi, T. Regulation of immunity and oncogenesis by the IRF transcription factor family. Cancer Immunol. Immunother. 59, 489\u2013510 (2010).","journal-title":"Cancer Immunol. Immunother."},{"key":"BFncomms4303_CR34","doi-asserted-by":"crossref","unstructured":"Ikushima, H., Negishi, H. & Taniguchi, T. The IRF family transcription factors at the interface of innate and adaptive immune responses. Cold Spring Harb. Symp. Quant. Biol doi:10.1101\/sqb.2013.78.020321 (2013).","DOI":"10.1101\/sqb.2013.78.020321"},{"key":"BFncomms4303_CR35","doi-asserted-by":"publisher","first-page":"21269","DOI":"10.1074\/jbc.M110.100818","volume":"285","author":"J Zhang","year":"2010","unstructured":"Zhang, J. et al. Activation of IL-27 p28 gene transcription by interferon regulatory factor 8 in cooperation with interferon regulatory factor 1. J. Biol. Chem. 285, 21269\u201321281 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFncomms4303_CR36","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.coviro.2011.11.001","volume":"1","author":"DE Levy","year":"2011","unstructured":"Levy, D. E., Marie, I. J. & Durbin, J. E. Induction and function of type I and III interferon in response to viral infection. Curr. Opin. Virol. 1, 476\u2013486 (2011).","journal-title":"Curr. Opin. Virol."},{"key":"BFncomms4303_CR37","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s00395-012-0326-9","volume":"108","author":"J Lu","year":"2013","unstructured":"Lu, J. et al. Interferon regulatory factor 3 is a negative regulator of pathological cardiac hypertrophy. Basic. Res. Cardiol. 108, 326 (2013).","journal-title":"Basic. Res. Cardiol."},{"key":"BFncomms4303_CR38","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1161\/HYPERTENSIONAHA.113.02083","volume":"63","author":"DS Jiang","year":"2013","unstructured":"Jiang, D. S. et al. Interferon regulatory factor 9 protects against cardiac hypertrophy by targeting myocardin. Hypertension 63, 119\u2013127 (2013).","journal-title":"Hypertension"},{"key":"BFncomms4303_CR39","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1161\/CIRCULATIONAHA.110.942268","volume":"122","author":"I Kehat","year":"2010","unstructured":"Kehat, I. & Molkentin, J. D. Molecular pathways underlying cardiac remodeling during pathophysiological stimulation. Circulation 122, 2727\u20132735 (2010).","journal-title":"Circulation"},{"key":"BFncomms4303_CR40","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.yjmcc.2011.02.012","volume":"50","author":"P Shanmugam","year":"2011","unstructured":"Shanmugam, P. et al. Angiotensin-II type 1 receptor and NOX2 mediate TCF\/LEF and CREB dependent WISP1 induction and cardiomyocyte hypertrophy. J. Mol. Cell. Cardiol. 50, 928\u2013938 (2011).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"BFncomms4303_CR41","doi-asserted-by":"publisher","first-page":"262","DOI":"10.2174\/157340311799960618","volume":"7","author":"S Kohli","year":"2011","unstructured":"Kohli, S., Ahuja, S. & Rani, V. Transcription factors in heart: promising therapeutic targets in cardiac hypertrophy. Curr. Cardiol. Rev. 7, 262\u2013271 (2011).","journal-title":"Curr. Cardiol. Rev."},{"key":"BFncomms4303_CR42","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1042\/CS20100084","volume":"119","author":"CZ Chiu","year":"2010","unstructured":"Chiu, C. Z., Wang, B. W., Chung, T. H. & Shyu, K. G. Angiotensin II and the ERK pathway mediate the induction of myocardin by hypoxia in cultured rat neonatal cardiomyocytes. Clin. Sci. (Lond) 119, 273\u2013282 (2010).","journal-title":"Clin. Sci. (Lond)"},{"key":"BFncomms4303_CR43","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1161\/01.RES.0000184684.88750.FE","volume":"97","author":"C Badorff","year":"2005","unstructured":"Badorff, C., Seeger, F. H., Zeiher, A. M. & Dimmeler, S. Glycogen synthase kinase 3beta inhibits myocardin-dependent transcription and hypertrophy induction through site-specific phosphorylation. Circ. Res. 97, 645\u2013654 (2005).","journal-title":"Circ. Res."},{"key":"BFncomms4303_CR44","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1161\/CIRCULATIONAHA.106.656835","volume":"115","author":"HL Li","year":"2007","unstructured":"Li, H. L. et al. Targeted cardiac overexpression of A20 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction. Circulation 115, 1885\u20131894 (2007).","journal-title":"Circulation"},{"key":"BFncomms4303_CR45","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00395-011-0239-z","volume":"107","author":"J Xiao","year":"2012","unstructured":"Xiao, J. et al. Cellular FLICE-inhibitory protein protects against cardiac remodelling after myocardial infarction. Basic Res. Cardiol. 107, 239 (2012).","journal-title":"Basic Res. Cardiol."},{"key":"BFncomms4303_CR46","doi-asserted-by":"publisher","first-page":"15081","DOI":"10.1074\/jbc.M702679200","volume":"282","author":"S de Frutos","year":"2007","unstructured":"de Frutos, S., Spangler, R., Alo, D. & Bosc, L. V. NFATc3 mediates chronic hypoxia-induced pulmonary arterial remodeling with alpha-actin up-regulation. J. Biol. Chem. 282, 15081\u201315089 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFncomms4303_CR47","doi-asserted-by":"publisher","first-page":"7000","DOI":"10.1073\/pnas.1001825107","volume":"107","author":"X Wu","year":"2010","unstructured":"Wu, X., Eder, P., Chang, B. & Molkentin, J. D. TRPC channels are necessary mediators of pathologic cardiac hypertrophy. Proc. Natl Acad. Sci. USA 107, 7000\u20137005 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncomms4303.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncomms4303","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms4303.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T03:56:52Z","timestamp":1672977412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncomms4303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,14]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,5,20]]}},"alternative-id":["BFncomms4303"],"URL":"https:\/\/doi.org\/10.1038\/ncomms4303","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,14]]},"assertion":[{"value":"23 July 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3303"}}